Abstract
Assessments of lysergic acid diethylamide (LSD) in the treatment of alcoholism have not been based on quantitative meta-analysis. Hence, we performed a meta-analysis of randomized controlled trials in order to evaluate the clinical efficacy of LSD in the treatment of alcoholism. Two reviewers independently extracted the data, pooling the effects using odds ratios (ORs) by a generic inverse variance, random effects model. We identified six eligible trials, including 536 participants. There was evidence for a beneficial effect of LSD on alcohol misuse (OR, 1.96; 95% CI, 1.36–2.84; p = 0.0003). Between-trial heterogeneity for the treatment effects was negligible (I2 = 0%). Secondary outcomes, risk of bias and limitations are discussed. A single dose of LSD, in the context of various alcoholism treatment programs, is associated with a decrease in alcohol misuse.
References
Section:
| Ables MF, Eng EW (1967) Group treatment of chronic alcoholism with LSD-25. In: Highlights of the twelfth annual conference in cooperative studies in psychiatry. Perry Point, MD: Veterans Administration Central Neuropsychiatric Research Laboratory. Google Scholar | |
| Ables MF, Eng EW, Curtin ME (1970) Group treatment of chronic alcoholism with LSD-25: study II. Newsletter for research in psychology, United States Veterans Administration 12: 17–21. Google Scholar | |
| Albaugh BJ, Anderson PO (1974) Peyote in the treatment of alcoholism among American Indians. Am J Psychiatry 131: 1247–1250. Google Scholar Medline | |
| American Psychiatric Association (1952) Diagnostic and Statistical Manual for Mental Disorders. First Edition. Washington, DC: American Psychiatric Association, 39. Google Scholar | |
| Bowen WT, Soskin RA, Chotlos JW (1970) Lysergic acid diethylamide as a variable in the hospital treatment of alcoholism: a follow-up study. J Nerv Ment Dis 150: 111–118. Google Scholar CrossRef, Medline | |
| Bruhn JG, De Smet PA, El-Seedi HR, Beck O (2002) Mescaline use for 5700 years. Lancet 359: 1866. Google Scholar Medline | |
| Denson R, Sydiaha D (1970) A controlled study of LSD treatment in alcoholism and neurosis. Br J Psychiatry 116: 443–445. Google Scholar Medline | |
| Ditman KS, Moss T, Forgy E, . (1970) Characteristics of alcoholics volunteering for lysergide treatment. Q J Stud Alcohol 31: 414–422. Google Scholar Medline | |
| Dyck E (2008) Psychedelic Psychiatry: LSD from Clinic to Campus. Baltimore, MD: Johns Hopkins University Press. Google Scholar | |
| Fábregas JM, González D, Fondevila S, . (2010) Assessment of addiction severity among ritual users of ayahuasca. Drug Alcohol Depend 111: 257–261. Google Scholar CrossRef, Medline | |
| Griffiths RR, Richards WA, McCann U, Jesse R (2006) Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl) 187: 268–283. Google Scholar CrossRef, Medline | |
| Grob CS, Danforth AL, Chopra GS, . (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 68: 71–78. Google Scholar CrossRef, Medline | |
| Henderson LH, Glass WJ (1994) LSD: Still With Us After All These Years. New York: Lexington Books. Google Scholar | |
| Higgins JPT, Altman DG (2008) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 (updated September 2008). Cochrane Collaboration. Available at: http://www.cochrane-handbook.org Google Scholar | |
| Hollister LE, Shelton J, Krieger G (1969) A controlled comparison of lysergic acid diethylamide (LSD) and dextroamphetmine in alcoholics. Am J Psychiatry 125: 1352–1357. Google Scholar CrossRef, Medline | |
| Jensen SE (1962) A treatment program for alcoholics in a mental hospital. Q J Stud Alcohol 23: 315–320. Google Scholar Medline | |
| Jensen SE (1963) Treatment of chronic alcoholism with lysergic acid diethylamide. Can Psychiatr Assoc J 8: 182–188. Google Scholar Abstract | |
| Johnson FG (1969) LSD in the treatment of alcoholism. Am J Psychiatry 126: 481–487. Google Scholar Medline | |
| Johnson M, Richards W, Griffiths R (2008) Human hallucinogen research: guidelines for safety. J Psychopharmacol 22: 603–620. Google Scholar Link | |
| Krampe H, Ehrenreich H (2010) Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des 16: 2076–2090. Google Scholar Medline | |
| Kurland AA, Savage C, Pahnke WN, Grof S, Olsson JE (1971) LSD in the treatment of alcoholism. In: Vinar O, Votava Z, Bradley PB (eds) Advances in neuropsychopharmacology: proceedings of the 7th congress of the collegium internationale neuro-psychopharmacologicum. Amsterdam: North-Holland, 361–372. Google Scholar | |
| Ludwig AM, Levine J, Stark L, Lazar R (1969) A clinical study of LSD treatment in alcoholism. Am J Psychiatry 126: 59–69. Google Scholar CrossRef, Medline | |
| Ludwig AM, Levine J, Stark LH (1970) LSD and alcoholism: a clinical study of treatment efficacy. Springfield, IL: Charles C Thomas. Google Scholar | |
| Mangini M (1998) Treatment of alcoholism using psychedelic drugs: a review of the program of research. J Psychoactive Drugs 30: 381–418. Google Scholar CrossRef, Medline | |
| McGlothlin WH (1964) Hallucinogenic Drugs: A Perspective with Special Reference to Peyote and Cannabis. Santa Monica, CA: RAND Corporation. Available at: http://www.rand.org/pubs/papers/P2937.html (accessed 25 February 2012). Google Scholar | |
| Nutt DJ, King LA, Phillips LD (2010) Drug harms in the UK: a multicriteria decision analysis. Lancet 376: 1558–1565. Google Scholar CrossRef, Medline | |
| Osmond H, Albahary R, Cheek F, Sarett M (1967) Some problems in the use of LSD 25 in the treatment of alcoholism. In: Abramson HA (ed) The use of LSD in psychotherapy and alcoholism. Indianapolis, IN: Bobbs-Merrill, 434–457. Google Scholar | |
| Pahnke WN, Kurland AA, Unger S, Savage C, Grof S (1970) The experimental use of psychedelic (LSD) psychotherapy. JAMA 212: 1856–1863. Google Scholar CrossRef, Medline | |
| Passie T, Halpern JH, Stichtenoth DO, Emrich HM, Hintzen A (2008) The pharmacology of lysergic acid diethylamide: a review. CNS Neurosci Ther 14: 295–314. Google Scholar CrossRef, Medline | |
| Rehm J, Mathers C, Popova S, . (2009) Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373: 2223–2233. Google Scholar CrossRef, Medline | |
| Rösner S, Hackl-Herrwerth A, Leucht S, . (2010a) Acamprosate for alcohol dependence. Cochrane Database Syst Rev 9: CD004332. Google Scholar | |
| Rösner S, Hackl-Herrwerth A, Leucht S, . (2010b) Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 12: CD001867. Google Scholar | |
| Savage C, McCabe OL (1973) Residential psychedelic (LSD) therapy for the narcotic addict. Arch Gen Psychiatry 28: 808–814. Google Scholar CrossRef, Medline | |
| Schuckit MA (2009) Alcohol-use disorders. Lancet 373: 492–501. Google Scholar CrossRef, Medline | |
| Smart RG, Storm T, Baker EF, Solursh L (1966) A controlled study of lysergide in the treatment of alcoholism. 1. The effects on drinking behavior. Q J Stud Alcohol 27: 469–482. Google Scholar Medline | |
| Smart RG, Storm T, Baker EF, Solursh L (1967) Lysergic acid diethylamide (LSD) in the treatment of alcoholism; an investigation of its effects on drinking behavior, personality structure, and social functioning. Toronto: Published for the Alcoholism and Drug Addiction Research Foundation of Ontario: University of Toronto Press. Google Scholar | |
| Studerus E, Kometer M, Hasler F, Vollenweider FX (2011) Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. J Psychopharmacol. 25: 4135–4152. Google Scholar | |
| Tomsovic M, Edwards RV (1970) Lysergide treatment of schizophrenic and nonschizophrenic alcoholics: a controlled evaluation. Q J Stud Alcohol 31: 932–949. Google Scholar | |
| Van Dusen W, Wilson W, Miners W, Hook H (1967) Treatment of alcoholism with lysergide. Q J Stud Alcohol 28: 295–304. Google Scholar Medline |
